11 November 2020 : Clinical Research
Serum Interleukin-6 Concentrations and the Severity of COVID-19 Pneumonia: A Retrospective Study at a Single Center in Bengbu City, Anhui Province, China, in January and February 2020
Hong Sun1CE, Pu Guo1BD, Lunjun Zhang1DF, Fengchao Wang1A*DOI: 10.12659/MSM.926941
Med Sci Monit 2020; 26:e926941
Table 1 Baseline demographic and clinical characteristics of patients with coronavirus disease-2019 (COVID-19).
| No. (%)Total (N=68) | Severe group | General group | p Value | |
|---|---|---|---|---|
| Sex | >0.05 | |||
| Female | 31 (45.6%) | 20 | 11 | |
| Male | 37 (54.4%) | 20 | 17 | |
| Age | 59.75±12.67 | 52.94±11.11 | >0.05 | |
| Comorbidities | ||||
| Diabetes | 2 (2.9%) | 1 | 1 | >0.05 |
| Hypertension | 14 (20.6%) | 9 | 5 | <0.05 |
| Cardiovascular disease | 1 (1.5%) | 1 | >0.05 | |
| Interleukin-6 | 45.66±72.35 | 10.63±22.63 | <0.01 |